Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
9.43
+0.59 (6.62%)
At close: Jul 1, 2025, 4:00 PM
9.43
0.00 (0.00%)
After-hours: Jul 1, 2025, 4:00 PM EDT
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $139.05 million as of July 1, 2025. Its market cap has decreased by -78.69% in one year.
Market Cap
139.05M
Enterprise Value
-135.03M
1-Year Change
-78.69%
Ranking
Category
Stock Price
$9.43
Market Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $139.05M, a decrease of -96.63%. That is a compound annual growth rate of -56.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2025 | 130.90M | -29.99% |
| Dec 31, 2024 | 186.98M | -61.73% |
| Dec 29, 2023 | 488.63M | -43.52% |
| Dec 30, 2022 | 865.16M | -53.52% |
| Dec 31, 2021 | 1.86B | -54.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.42B |
| Johnson & Johnson | 365.34B |
| AbbVie | 327.00B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.75B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 235.50B |
| AstraZeneca | 217.42B |